Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry

Nicky van der Heijde; Frederique L Vissers; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS); Alberto Manzoni; Giuseppe Zimmitti; Joaquim Balsells; Frederik Berrevoet; Bergthor Bjornsson; Peter van den Boezem; Ugo Boggi; Svein O Bratlie; Fernando Burdio; Andrea Coratti; Mathieu D'Hondt; Carlos D Del Pozo; Safi Dokmak; Regis Fara; Mehmet F Can; Sebastiaan Festen; Antonello Forgione; Claus Fristrup; Sebastien Gaujoux; Bas Groot Koerkamp; Thilo Hackert; Igor E Khatkov; Tobias Keck; Hanna Seppänen; Daan Lips; Misha Luyer; Gabriella Pittau; Manuel Maglione; I Quintus Molenaar; Patrick Pessaux; Geert Roeyen; Olivier Saint-Marc; Santiago S Cabus; Hjalmar van Santvoort; George van der Schelling; Mario Serradilla-Martin; Francois-Regis Souche; Miguel Á Suarez Muñoz; Marco V Marino; Marc G Besselink; Mohammed Abu Hilal

doi:10.1016/j.hpb.2022.07.015

Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry

Nicky van der Heijde
, Frederique L Vissers
, European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)
, Alberto Manzoni
, Giuseppe Zimmitti
, Joaquim Balsells
, Frederik Berrevoet
, Bergthor Bjornsson
, Peter van den Boezem
, Ugo Boggi
, Svein O Bratlie
, Fernando Burdio
, Andrea Coratti
, Mathieu D'Hondt
, Carlos D Del Pozo
, Safi Dokmak
, Regis Fara
, Mehmet F Can
, Sebastiaan Festen
, Antonello Forgione

Claus Fristrup, Sebastien Gaujoux, Bas Groot Koerkamp, Thilo Hackert, Igor E Khatkov, Tobias Keck, Hanna Seppänen, Daan Lips, Misha Luyer, Gabriella Pittau, Manuel Maglione, I Quintus Molenaar, Patrick Pessaux, Geert Roeyen, Olivier Saint-Marc, Santiago S Cabus, Hjalmar van Santvoort, George van der Schelling, Mario Serradilla-Martin, Francois-Regis Souche, Miguel Á Suarez Muñoz, Marco V Marino, Marc G Besselink^*, Mohammed Abu Hilal^*

^*Corresponding author for this work

Surgery

Amsterdam UMC, Locatie VUmc
Istituto Ospedaliero Fondazione Poliambulanza
Vall d'Hebron Institute of Oncology
Ghent University Hospital
Linköping University
Radboud University Medical Center
Azienda Ospedaliera Universitá Pisana University of Pisa
Sahlgrenska University Hospital (Mölndal)
Hospital del Mar Medical Research Institute (IMIM)
Azienda Ospedaliera Careggi
AZ Groeninge
Hospital Universitario doctor Peset
Beaujon Hospital
Hôpital Européen Marseille
Lokman Hekim Ankara Hospital
Asst Grande Ospedale Metropolitano Niguarda
Odense University Hospital
Hospital Cochin
Heidelberg University
Moscow Clinical Scientific Center
UKSH Campus Lübeck
Helsinki University Central Hospital
Kantongerecht Enschede
Catharina Hospital
Hôpital Paul Brousse
Innsbruck Medical University
Regional Academic Cancer Center Utrecht
Nouvel Hopital Civil - Institut Hospitalo-Universitaire de Strasbourg
Antwerp University Hospital and University of Antwerp
Centre Hospitalier Regional D'Orleans
Hospital Sant Pau
Amphia Hospital
University Children Miguel Servet Hospital
Centre Hospitalier Universitaire de Montpellier
Virgen de la Victoria University Hospital Málaga
Azienda OspedalieraOspedali Riuniti VillaSofia Cervello
University Hospital Southampton NHS Foundation Trust
Amsterdam UMC
University of Amsterdam
Cancer Center Amsterdam (CCA)
Onze Lieve Vrouwe Gasthuis

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Abstract

BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.

METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.

RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD.

CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.

Original language	English
Pages (from-to)	400-408
Number of pages	9
Journal	HPB
Volume	25
Issue number	4
DOIs	https://doi.org/10.1016/j.hpb.2022.07.015
Publication status	Published - Apr 2023

Bibliographical note

Publisher Copyright:
© 2022

Access to Document

10.1016/j.hpb.2022.07.015

Cite this

van der Heijde, N., Vissers, F. L., European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS), Manzoni, A., Zimmitti, G., Balsells, J., Berrevoet, F., Bjornsson, B., van den Boezem, P., Boggi, U., Bratlie, S. O., Burdio, F., Coratti, A., D'Hondt, M., Del Pozo, C. D., Dokmak, S., Fara, R., Can, M. F., Festen, S., ... Abu Hilal, M. (2023). Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry. HPB, 25(4), 400-408. https://doi.org/10.1016/j.hpb.2022.07.015

@article{1644f44305034f26ab14a07accbebc05,

title = "Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry",

abstract = "BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0\% (IQR 39.0-77.3\%) and median use of MIPD 27.7\% (IQR 9.7-45.3\%). MIDP was mostly performed laparoscopic (401/558, 71.9\%) and MIPD mostly robotic (234/401, 58.3\%). MIPD was performed in 50/54 (89.3\%) centers, of which 15/50 (30.0\%) performed ≥20 MIPD annually. This was 30/54 (55.6\%) centers and 13/30 (43\%) centers for MIPD respectively. Conversion rate was 10.9\% for MIDP and 8.4\% for MIPD. Overall 90 day mortality was 1.1\% (n = 6) for MIDP and 3.7\% (n = 15) for MIPD.CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.",

author = "\{van der Heijde\}, Nicky and Vissers, \{Frederique L\} and \{European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)\} and Alberto Manzoni and Giuseppe Zimmitti and Joaquim Balsells and Frederik Berrevoet and Bergthor Bjornsson and \{van den Boezem\}, Peter and Ugo Boggi and Bratlie, \{Svein O\} and Fernando Burdio and Andrea Coratti and Mathieu D'Hondt and \{Del Pozo\}, \{Carlos D\} and Safi Dokmak and Regis Fara and Can, \{Mehmet F\} and Sebastiaan Festen and Antonello Forgione and Claus Fristrup and Sebastien Gaujoux and \{Groot Koerkamp\}, Bas and Thilo Hackert and Khatkov, \{Igor E\} and Tobias Keck and Hanna Sepp{\"a}nen and Daan Lips and Misha Luyer and Gabriella Pittau and Manuel Maglione and Molenaar, \{I Quintus\} and Patrick Pessaux and Geert Roeyen and Olivier Saint-Marc and Cabus, \{Santiago S\} and \{van Santvoort\}, Hjalmar and \{van der Schelling\}, George and Mario Serradilla-Martin and Francois-Regis Souche and \{Suarez Mu{\~n}oz\}, \{Miguel {\'A}\} and Marino, \{Marco V\} and Besselink, \{Marc G\} and \{Abu Hilal\}, Mohammed",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2023",

month = apr,

doi = "10.1016/j.hpb.2022.07.015",

language = "English",

volume = "25",

pages = "400--408",

journal = "HPB",

issn = "1365-182X",

publisher = "Elsevier",

number = "4",

}

van der Heijde, N, Vissers, FL, European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS), Manzoni, A, Zimmitti, G, Balsells, J, Berrevoet, F, Bjornsson, B, van den Boezem, P, Boggi, U, Bratlie, SO, Burdio, F, Coratti, A, D'Hondt, M, Del Pozo, CD, Dokmak, S, Fara, R, Can, MF, Festen, S, Forgione, A, Fristrup, C, Gaujoux, S, Groot Koerkamp, B, Hackert, T, Khatkov, IE, Keck, T, Seppänen, H, Lips, D, Luyer, M, Pittau, G, Maglione, M, Molenaar, IQ, Pessaux, P, Roeyen, G, Saint-Marc, O, Cabus, SS, van Santvoort, H, van der Schelling, G, Serradilla-Martin, M, Souche, F-R, Suarez Muñoz, MÁ, Marino, MV, Besselink, MG & Abu Hilal, M 2023, 'Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry', HPB, vol. 25, no. 4, pp. 400-408. https://doi.org/10.1016/j.hpb.2022.07.015

TY - JOUR

T1 - Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry

AU - van der Heijde, Nicky

AU - Vissers, Frederique L

AU - European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)

AU - Manzoni, Alberto

AU - Zimmitti, Giuseppe

AU - Balsells, Joaquim

AU - Berrevoet, Frederik

AU - Bjornsson, Bergthor

AU - van den Boezem, Peter

AU - Boggi, Ugo

AU - Bratlie, Svein O

AU - Burdio, Fernando

AU - Coratti, Andrea

AU - D'Hondt, Mathieu

AU - Del Pozo, Carlos D

AU - Dokmak, Safi

AU - Fara, Regis

AU - Can, Mehmet F

AU - Festen, Sebastiaan

AU - Forgione, Antonello

AU - Fristrup, Claus

AU - Gaujoux, Sebastien

AU - Groot Koerkamp, Bas

AU - Hackert, Thilo

AU - Khatkov, Igor E

AU - Keck, Tobias

AU - Seppänen, Hanna

AU - Lips, Daan

AU - Luyer, Misha

AU - Pittau, Gabriella

AU - Maglione, Manuel

AU - Molenaar, I Quintus

AU - Pessaux, Patrick

AU - Roeyen, Geert

AU - Saint-Marc, Olivier

AU - Cabus, Santiago S

AU - van Santvoort, Hjalmar

AU - van der Schelling, George

AU - Serradilla-Martin, Mario

AU - Souche, Francois-Regis

AU - Suarez Muñoz, Miguel Á

AU - Marino, Marco V

AU - Besselink, Marc G

AU - Abu Hilal, Mohammed

PY - 2023/4

Y1 - 2023/4

N2 - BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD.CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.

AB - BACKGROUND: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe.METHODS: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality.RESULTS: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7-20) and 9 (2-20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0-77.3%) and median use of MIPD 27.7% (IQR 9.7-45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD.CONCLUSION: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.

UR - https://www.scopus.com/pages/publications/85151563636

U2 - 10.1016/j.hpb.2022.07.015

DO - 10.1016/j.hpb.2022.07.015

M3 - Article

C2 - 37028826

SN - 1365-182X

VL - 25

SP - 400

EP - 408

JO - HPB

JF - HPB

IS - 4

ER -

Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this